Intermedical Care and Lab Hospital Public Company Limited
Climate Impact & Sustainability Data (2019, 2022)
Reporting Period: 2019
Environmental Metrics
ESG Focus Areas
- Social Responsibility
- Corporate Governance
- Risk Management
Environmental Achievements
- Operation rooms certified for ISO 15189:2012 and 15190:2003 medical laboratories by the Bureau of Laboratory Quality Standard, Ministry of Public Health.
Social Achievements
- Children’s Day 2019 Activity
- Charity Activity
- Donation to Industrial Development Foundation
Governance Achievements
- Established Anti-Corruption policy and disseminated to all departments.
- Prepared Code of Conduct for executives and employees.
- Prepared preventive measures against conflict of interest.
Climate Goals & Targets
Environmental Challenges
- Shortage of medical personnel and specialized personnel
- Risk from litigation
- Risk from competition
- Risk from revenue fluctuation by season
- Risks from sublease from related persons for establishing a branch
- Risks from trading shares from shareholders
- Risks from having more than 50 percent of major shareholders
- Risk of fluctuation of share price
Mitigation Strategies
- Outsourcing part-time medical personnel
- Improving working environment and occupational hygiene
- Providing training to improve working skills
- Developing medical personnel network
- Prioritizing quality and standard, procedures and services
- Applying for ISO 9001:2015 and ISO/IEC 17025:2005
- Assessing service quality and customer satisfaction
- Broadening scope of service
- Acquiring the land and owning property
- Preparing management structure with competent personnel
- Appointing independent external person in the Board of Directors
- Establishing internal audit unit
Supply Chain Management
Responsible Procurement
- precise procurement steps
Climate-Related Risks & Opportunities
Reporting Period: 2022
Environmental Metrics
Total Energy Consumption:504,622 kW/year
Water Consumption:5,547 m3/year
Waste Generated:11,479 kg/year
ESG Focus Areas
- Good corporate governance
- Quality control of medical services
- Environmental quality management
- Human rights
- Community development
Environmental Achievements
- Reduced electricity consumption by 21.34% compared to 2021 (504,622 kW vs 641,548 kW)
- Reduced water consumption by 32.90% compared to 2021 (5,547 cubic meters vs 8,267 cubic meters)
- Reduced infectious waste by 9.61% compared to 2021 (11,479 kg vs 12,689 kg)
Social Achievements
- Employee turnover rate of 7%
- Average training hours per employee: 36 hours/person
- Donated blood oxygen meters to Rat Burana Waiting Center
- Organized first aid and CPR training for students and personnel
Governance Achievements
- Corporate Governance Report of Thai Listed Companies (CGR) score of 89 points (Very Good)
- 100 points from the quality assessment of the 2020 Annual General Meeting of Shareholders
- Established a clear written corporate governance policy
Climate Goals & Targets
Environmental Challenges
- Shortage of medical personnel and specialized professionals
- Risk of litigation
- Competitive risks in the business
- Risk of seasonal income fluctuations
Mitigation Strategies
- Uses part-time medical personnel for on-site examinations
- Planned service issuance in advance
- Focuses on quality and standards, uses state-of-the-art equipment
- Implements ISO systems
- Assesses service quality and customer satisfaction
- More than 23 years of experience and expertise
- Provides services at various points throughout the country
- Continuously develops personnel and medical equipment
- Adjusts business strategy in accordance with changing circumstances
Supply Chain Management
Responsible Procurement
- Quarterly selection and evaluation of suppliers’ performance
- Compliance with trade conditions
- Equality in doing business
Climate-Related Risks & Opportunities
Reporting Standards
Frameworks Used: 56-1 ONE REPORT
Certifications: ISO 9001:2015, ISO/IEC 17025:2017, ISO 15189:2012, ISO 15190:2003
Awards & Recognition
- Moral Hospital award
- Hospital Accreditation (HA) Phase 2